Proactively manage your pharmacy inventory
Find generic entry opportunities
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
|Title:||Parenteral busulfan for treatment of malignant disease|
|Abstract:||Stable parenteral formulations of busulfan safe for parenteral administration are disclosed that exhibit improved bioavailability and optimize high dose busulfan therapy against malignant disease.|
|Inventor(s):||Andersson; Borje S. (Houston, TX), Bhagwatwar; Harshal P. (Houston, TX), Chow; Diana S. L. (Houston, TX)|
|Assignee:||Board of Regents, The University of Texas System (Austin, TX) University of Houston-University Park (Houston, TX)|
Patent Claim Types:|
see list of patent claims
|Formulation; Compound; Use; Composition;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.